Mineral content of calcified tissues in cystic fibrosis mice.
Although abnormal hard tissue mineralization is a recognized complication of cystic fibrosis (CF), the pathogenesis leading from the defective cystic fibrosis transmembrane conductance regulator (CFTR) protein is poorly understood. We hypothesized that CFTR plays a direct role in the mineralization of bone and teeth and tested the hypothesis using CF mouse models [CFTR(-) mice]. In vivo measurements by dual-emission X-ray absorpitometry (DEXA) indicated that bone mineral density (BMD) was reduced in CF mice as compared to gender-matched littermates. However, no change was evident after correction of BMD for the covariant of body weight. The latter finding was confirmed in isolated femurs and nasal bones by standard dry-ashing and instrumental neutron activation analysis (INAA). INAA of the continuously growing hypsodont incisor teeth from CFTR(-) mice revealed reduced Ca and normal P in the enamel layer--a finding consistent with changes in the deciduous teeth of CF children. Interestingly, enamel fluoride was increased in the CFTR(-) incisors and may associate with abnormal enamel crystallite formation. The iron content of the incisor enamel was reduced, explaining the loss of yellow pigmentation in CFTR(-) incisors. In contrast to the incisors, the mineral content of the slow-growing brachydont molar teeth was not different between CFTR(-) and CFTR(+) mice. It was concluded that CFTR does not play a direct role in the mineralization of bones or brachydont teeth in mice. Functional CFTR is apparently required for normal mineralization of the hypsodont incisors. However, multiple changes in the mineral composition of the CF incisors suggest an indirect role for CFTR, perhaps by maintaining a normal salivary environment for continuous tooth eruption.
Gawenis
L R
LR
Dalton Cardiovascular Research Center and the Department of Veterinary Biomedical Sciences, University of Missouri-Columbia, 65211, USA.
Spencer
P
P
Hillman
L S
LS
Harline
M C
MC
Morris
J S
JS
Clarke
L L
LL
D000818:Animals; D015519:Bone Density; D002114:Calcinosis / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism; D002648:Child; D003550:Cystic Fibrosis / Q000235:genetics / Q000378:metabolism*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D007408:Intestinal Absorption; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D008817:Mice, Mutant Strains; D008903:Minerals / Q000378:metabolism*; D014070:Tooth / Q000378:metabolism
C505032:CFTR protein, human; D008903:Minerals; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D002118:Calcium